Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...
Medical Device Network on MSN
Prodeon Medical’s BPH implant gains FDA clearance
In data supporting FDA approval, 48.1% implanted with Prodeon’s Urocross saw International Prostate Symptom Score ...
Image courtesy of Prodeon Medical] Prodeon Medical announced today that it received FDA 510(k) clearance for its Urocross ...
Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic ...
Procept BioRobotics today announced the international rollout of its next-generation Hydros robotic system for Aquablation ...
Men suffering from the disruptive symptoms of an enlarged prostate now have a new treatment option available at East Georgia ...
Safer Minimally Invasive Treatments in High-Risk & Comorbid Patients with Prostate Enlargement (BPH)
Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...
Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...
Generic competition has markedly reduced the cost of medications for benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS), potentially reshaping the value proposition of ...
During a routine medical check-up, a small nodule was discovered in former U.S. President Joe Biden’s prostate. The news, confirmed by his spokesperson, prompted concern and called for further ...
In fact, urinary-related symptoms are common — particularly as men age — and a majority of the time, they're not an indication of cancer. “The prostate naturally grows over time, which can narrow the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results